Technology

Patient Identification in Healthcare: Unlocking Technology to Improve Patient Safety

Michael Trader, Co-Founder and President of RightPatient, the most innovative and comprehensive patient identification solution that increases patient safety, reduces costs, improves the quality of care, and enhances the patient experience joins eHealth Radio and the Healthcare and Technology Channels.
Listen to interview with host Eric Michaels & guest Michael Trader discuss the following:It’s been a few months since we last spoke. Can you catch us up on what RightPatient has been doing since we spoke last fall?Seamless EHR integration is an important attribute of biometric patient identification solutions. Can you tell us why this is important and how your solution addresses seamless EHR integration?Many of those researching the implementation of biometric patient identification solutions may not understand the impact of this technology on revenue cycle management. What can you tell us about the impact of this technology on a hospital’s revenue cycle, and why is this important to understand?Why is experience in biometric s an important vendor characteristic to evaluate when vetting biometric patient identification solutions?I noticed that the College of Healthcare Information Executives (CHIME) and HeroX launched their national patient ID challenge in January, and AHIMA just launched a petition initiative to ask Congress to lift the (mora-torium) moratorium on funding research on a national patient ID credential. What can you tell us about the CHIME and AHIMA initiatives and does RightPatient plan on submitting a proposal for CHIME’s contest?
Duration: 9:17
A serial entrepreneur with a passion for innovation, Michael has been an early-stage and founding member of several successful technology companies in the areas of strategic sourcing, biometrics, and healthcare.  He has advised dozens of Fortune 1000 companies, traveled to more than 30 countries, is a frequent presenter at various healthcare symposiums, and has been interviewed by media and research outlets such as CNN, Fortune Magazine, Health Data Management, and Frost & Sullivan. 
At RightPatient, Michael is responsible for overseeing business development and marketing activities, government outreach, and for providing senior leadership on business and policy issues.  Michael holds a BS degree in Biological Sciences from the University of Vermont where he graduated with honors.

Website: www.rightpatient.com
Social Media Links:
Facebook: www.facebook.com/RightPatient
Twitter: @RightPatient
Are you enjoying the podcast? Please, leave a review.

Stress and Focus Management

Dr. Oren Fuerst, Chairman and Founder of Eco Fusion, a company that develops digital therapies, the first one dealing with stress and focus joins eHealth Radio and the Health News, Stress Management and Technology Channels.
Listen to interview with host Eric Michaels & guest Dr. Oren Fuerst discuss the following:Tell us about your product- What gave you the idea for the Serenita app?Do you have clinical evidence of the efficacy of your solution?What other apps/products does the company have in development? Are they more sophisticated?What can you say about the competing apps in the market and why yours is different?
Duration: 6:52
Dr. Oren Fuerst is a serial entrepreneur, investor, advisor and inventor, focused on digital health initiatives. Chairman of Strategic Models/Fuerst Technologies, a New York-based ideas nurturing and advisory boutique, and the co-founder of multiple technology companies. The health companies he co-founded in recent years: Medivizor, a personalized health information company; Eco-Fusion, a digital drugs company dealing with more than 10 indications; LabStyle Innovations (OTCBB:DRIO), a diabetes management company (creator of the Dario device); and Circ MedTech, an HIV prevention medical devices company (creator of the PrePex device). He also co-founded Tevel, a global network of investors focused on Israeli-related technology companies. He was the initiator and co-Director of the Technology Valuation Executive Program at Columbia Business School, and served as a faculty member at Yale University School of Management and Yale International Center for Finance.  He had published multiple academic papers and popular press articles in newspapers such as the Financial Times and published multiple books with publishers including Prentice Hall.
Dr. Fuerst had advised multiple private and public corporates on a variety of issues including strategy, technology assessment, valuation and intellectual property. He had invented (holds multiple granted patents) and commercialized health technologies with companies including Becton Dickinson (NYSE:BDX). Dr. Fuerst is also involved in numerous not for profit organizations, including serving on the boards of the American Friends of Sheba Medical Center and Global Imagine. He is a mentor at the Microsoft Ventures and Israel Brain Technology Accelerators. Dr. Fuerst holds a Ph.D. from Columbia Business School. He holds a dual bachelor’s degree from Tel Aviv University (Dual Magna Cum Laude) in Accounting and Economics. He was a commander at an Elite technology Unit of the Israeli Defense Forces.

Website: www.eco-fusion.com

NxStage System One: The only portable hemodialysis system FDA-cleared

Jeff Burbank, CEO of NX STAGE Medical, a medical device company that develops, manufactures and markets systems for the treatment of end-stage renal disease, acute kidney failure and fluid overload joins eHealth Radio and the Health Care, Health News, Kidney Health and Technology Channels.
Listen to interview with host Eric Michaels & guest Jeff Burbank discuss the following:Can you please us about your company NX Stage Medical and what exactly your company does?Can you discuss the NxStage System One, which is the only “portable” hemodialysis system FDA-cleared for home hemodialysis and home nocturnal hemodialysis.What difference does this product make in people’s lives?How has the Affordable Health Act, Obamacare, impacted your business and insurance coverage of your product to your customers?Your product is available around the world. Are there certain parts of the world where your products are used more than other parts of the world when it comes to the nx stage system one?I saw that that 6 years after the earthquake in Haiti, the NxStage System One is still be used there to help folks suffering from acute kidney injury. Can you talk about that.I read recently that your publically traded company is doing well on the stock exchange, can you talk a about what your company’s prospects are in 2016 and the future and where you see your industry moving toward the future.Looking at your biography, I saw that during your career you had been an inventor on over 50 U.S. patents for medical devices. That’s pretty impressive. How did you get into this field and become so proficient and successful in the medical devices industry?
Duration: 10:26
Jeff Burbank is NxStage’s Founder, Chief Executive Officer, and is a member of its Board of Directors. Jeff has over 20 years of in-depth management experience with companies developing, marketing and manufacturing products for End Stage Renal Disease patients. He has led NxStage since its inception, guiding it through all of its developmental phases to the successful initiation and rapid growth of commercial activities, its initial public offering, and the acquisition of Medisystems.
Prior to founding NxStage, he co-founded Vasca, Inc., a company providing innovative implantable access devices, where he was the President and CEO, as well as Chairman of the Board. He gained significant renal industry experience during his nine years in the Renal Division at Gambro, Inc., with his last position as Director of Marketing and Advanced Technologies. During his career he has been an inventor on over 50 U.S. patents for medical devices.
Jeff received his BS in Industrial Engineering from Lehigh University.
About NxStage Medical
NxStage Medical Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.
About NxStage Kidney Care
NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), is innovating a dialysis care model that is intended to support and encourage patient centered care and provide enhanced access to the life-changing benefits of home therapy as well as flexible in-center options. By leveraging NxStage's home leadership and the innovative technology of its System One, NxStage Kidney Care is committed to helping patients take control of their dialysis and to allowing physicians the flexibility to prescribe what is truly best for their patients.

Website: www.nxstage.com

Why Everyone Should Use Telemedicine

Michael Okhravi, CEO of DocChat that lets patients communicate with doctors through real-time video which guarantees to connect patients to doctors in 15 minutes joins eHealth Radio and Health Care & Technology & Telemedicine Channels.
Listen to interview with host Eric Michaels & guest Michael Okhravi discuss the following:How can telemedicine help you improve your health?Who can most benefit from telemedicine?What ailments can be treated through telemedicine? What is the future of medicine beyond telemedicine?
Duration: 10:40
Mike Okhravi has a passion for building products that people will love. Driven by a desire for efficiency and results, Mike spent several years perfecting his knowledge of the Healthcare industry as a Business Developer for Emergency Medical Care.
Through his experiences, he became aware of the expansive list of problems within the Healthcare industry, driving him to co-launch DocChat. Because his desire for medical reform comes from personal experience, Mike understands the importance of strong doctor-patient relationships, which is hard to find in such a vast industry.
When he is not creating new ways to restore the medical industry through technology, Mike drinks wine and plays basketball, but not usually at the same time. Mike can be reached at mike@docchat.io, on Twitter, or on LinkedIn.

Website: www.docchat.io
Social Media:
Facebook: facebook.com/docchatapp
Twitter: @docchatapp

Secrets to an Effective Enterprise Imaging Strategy

Kim Garriott, Principal Consultant, Healthcare Strategies, for Logicalis Healthcare Solutions, and Jef Williams, COO of Ascendian Healthcare Consulting joins eHealth Radio and the Health Care and Technology Channels to talk about having an effective imaging strategy.
Listen to interview with host Eric Michaels and guests Kim Garriott & Jef Williams discuss the following:What is the role of governance in an Enterprise Imaging strategy?  Any best practices you’ve found?We hear a lot about analytics in healthcare today.  What role does analytics play with enterprise imaging?Viewing images is the most critical outcome of this initiative, so how are people finding success with deploying this?  Is it similar to the old PACS implementations? To date, most imaging acquisition workflows have been designed for the Radiology department and include many steps. How are organizations developing streamlined workflows to fit the needs of non-Radiology providers acquiring images at the point of care? There has been a lot of talk about finding an ROI in storage costs with an Enterprise Imaging model.  Have you found that to be true and are these “real” dollars? Most healthcare organizations are sharing images with their patients and other providers on CDs. What are the challenges created by the use of CDs and is there a better way to share this information?
Free eBook: www.us.logicalis.com/imagingebook
Kimberly Garriott, Principal Consultant, Healthcare StrategiesAs Principal Consultant for Logicalis Healthcare Solutions, Kim Garriott works with the Logicalis US healthcare sales team counseling clients on healthcare IT strategies and discussing the business value for potential healthcare IT projects as well as providing post-sale consulting to ensure the expected business value is achieved.  Whether talking with a health system’s CIO, CEO or medical staff, Kim understands the unique challenges they’re facing and excels in helping healthcare organizations create and execute a tactical plan that will meet their business objectives.

With a strong background in clinical imaging and workflow process improvement, Kim has more than two decades of business and IT leadership experience helping healthcare organizations streamline their workflow and project management processes.  Before joining Logicalis, Kim assisted with the design and implementation of the Cleveland Clinic’s enterprise imaging strategy.  Kim also served as CIO for the Pittsburgh-based Foundation Radiology Group, a multi-state radiology practice, and worked in a variety of director-level radiology informatics, process improvement and IT positions with Indiana University Health, an integrated healthcare provider.
Notably, Kim helped to create the HIMSS-SIIM Joint Enterprise Imaging Workgroup and continues to serve in a leadership capacity there, has been published in The Journal of the American College of Radiology as co-author of “Planning for PACS – A Comprehensive Guide to Non-Technical Considerations,” and is a regular speaker at national healthcare events.
Jef Williams, COO of Ascendian Healthcare Consulting
Being the COO for a major healthcare consulting firm requires someone who can meld management priorities, budget constraints and creativity, and that’s exactly what Jef Williams brings to Ascendian Healthcare Consulting. Wirth more than 20 years of project leadership experience working with both for-profit and not-for-profit organizations, Jef is both an extraordinary problem solver and is innovative in his decision making. His unique skills are a direct result of the wide array of experiences Jef has had throughout his career which include international relief efforts, business development, and complex information systems implementations.

Before joining Ascendian, Jef worked with some of the largest healthcare organizations in the United States, including GE Healthcare, where he received awards for his leadership and IT implementation achievements. Jef has also led project implementations and management teams at Sentara Healthcare, Sutter Health, Hospital Corporation of America (HCA) and Intermountain Healthcare, all of which contributed to his now extensive expertise in healthcare policy, administration, workflow, technology and infrastructure initiatives.
Jef earned his Bachelor of Arts degree from The Masters College and his Master of Business Administration from California State University, Sacramento. Today, he is both a PMI-certified Project Manager (PMP) and a Certified Imaging Informatics Professional (CIIP).

Accuro™: Automated 3D-Imaging Designed to Improve First-Attempt Success of Needle Guidance for Epidural Anesthesia

John WIlliams, the CEO at RIVANNA Medical, a commercial-stage company headquartered in Charlottesville, Virginia, that has developed and is selling FDA-cleared Accuro™, a smart-phone-sized device that automatically guides doctors for first-attempt success at delivering spinal anesthesia, such as an epidural for women in labor joins eHealth Radio and the Health Care, News & Technology Channels.
Listen to interview with host Eric Michaels and guest John WIlliams discuss the following: What is Accuro?What are the main benefits of using the device?Why do anesthesiologists and other doctors need Accuro?Taking it a bit further if you wold get into the accuracy of Accuro?What should one tell their doctor about Accuro?
Duration: 16:36
John A. Williams is an alum of Johnson & Johnson and Medtronic. He is a proven leader with distinguished success in building and selling publicly and privately held healthcare companies. He is known as a strong strategic and analytical thinker with a track record of developing new technologies to accelerate growth. He earned a bachelor’s degree in psychology at Boston University, where he played football and hockey. John also holds a master’s degree in industrial psychology from Springfield College.

Website: www.rivannamedical.com

ChroMedx, a medical technology company focused on vitro diagnostics and point-of-care testing

Wayne Maddever, CEO of ChroMedx, a medical technology company focused on the development of novel medical devices for in vitro diagnostics and point-of-care testing joins eHealth Radio and the Technology and Health Care Channels.
Listen to interview with host Eric Michaels and guest Wayne Maddever discuss the following: What is point of care testing (POCT) and describe key differences between the ones listeners are familiar with to the ones being worked on by your company?How are blood gas analyzers testing currently performed right now – can you see this process vastly improved today?What is the HemoPalm and how does this technology work?What are the ideal settings for the HemoPalm? Where is it needed the most?How do you see your tests empower doctors and first responders who do not have access to a lab? Where do you see it saving lives? When can we expect to use this technology?
Duration: 12:05
Wayne Maddever received his B.A.Sc./M.A.Sc/Ph.D. in Metallurgical and
Materials Science Engineering from the University of Toronto.  He began
his career with the Gas Products Division of Union Carbide (now
Praxair) in both the US and Canada where he held positions in research
and development, product management and sales management.  He has
considerable experience in the plastic moulding industry having headed a
Division of St. Lawrence Starch, which developed and commercialized
degradable plastics.  He is familiar with precision equipment
manufacture having served as General Manager of Sanden Machine, a
printing press manufacturer and as COO of CFN Precision, a precision
machining company producing parts for aircraft and scientific
instruments.  Dr. Maddever also operated Ontario’s third largest home
oxygen therapy and medical supply company as General Manager-Canada for
MG Industries a German industrial gases company.
Since 2000 he has
specialized in management of technically based companies where he has
held senior management positions at a number of technically based
private and publicly held companies, particularly in early stage or
turnaround situations.
Dr. Maddever holds several patents and is
the author of numerous technical papers in several different fields and
is co-author of a textbook on degradable plastics.

Website: www.chromedx.comFacebook: https://www.facebook.com/chromedxcorp
Twitter: @ChroMedXCorp

Disruption in Enrollment and Communication

Paul Smith, Chief Strategy and Revenue Officer at CodeBaby, a global customer engagement and intelligent virtual assistant technology provider joins eHealth Radio and the Health Care & Technology Channels.
Listen to interview with host Eric Michaels and guest Paul Smith discuss the following: How do you see the online self-service world in 5 years — in healthcare or otherwise?How are the disruptors in the market today changing the way they do business?What should enrollment firms be thinking about today to evolve and differentiate in the future?What strategic and tactical opportunities are on the horizon for public and private exchanges?  What should carriers be doing to win in the future?
Duration: 11:51
As Chief Strategy and Revenue Officer, Paul is responsible for driving company revenue in addition to developing, communicating, executing and sustaining strategic initiatives at CodeBaby.
His impressive results include driving revenue growth more than 300 percent in a two-year period at TeamShare, and 250 percent in a four-year period at Ziff Davis. His industry expertise includes training and consulting services technology, eBusiness consulting services to Fortune 500 global organizations and analysis and software for law enforcement.

Website: www.codebaby.com

Managing Diabetes in the Digital World – Introducing the DARIO

Todd Durniak, Executive VP of US Operations at  Labstyle Innovations that powers the DARIO, a unique diabetes management platform that allows patients and doctors seamlessly manage their condition joins eHealth Radio and the Diabetes, Health News & Technology Channels.Listen to interview with host Eric Michaels and guest Todd Durniak discuss the following: For those living with diabetes, what would you say is the major challenge in managing this condition today?How can your platform technology, Dario™ Diabetes Management Solution address this challenge? Can you explain how it works with smart devices such as phones and ipads? There’s a lot of technology out there to help People with Diabetes manage their disease.  How is DARIO different?Aside from the DARIO user, who else can access remotely the blood sugar meter readings? Why is this information important?  Labstyle Innovations has an online Facebook community called the DARIO Lounge. Why are these community groups so important in helping patients stay compliant and healthy? The DARIO platform also includes a suite of apps for the smartphone -- How do they work in the overall success for diabetic patients? Would the apps be available for non-diabetic patients?Can you share where the DARIO is currently available and when will be available for US patients?
Duration: 9:26

Todd Durniak is Labstyle Innovations’s Senior Vice President and General Manager for the U.S.  Durniak brings to LabStyle over 20 years of medical device commercial and technical leadership, most recently as the Vice President and General Manager of Neighborhood Diabetes, a division of Insulet focused on delivering insulin supplies through durable medical equipment (DME) and pharmacy channels with a 'high touch' training approach. 
Prior to Insulet and Neighborhood Diabetes, Durniak held a number of positions of increasing responsibility over 7 years at Smith & Nephew Orthopedics, most recently as President, Asia Pacific, based in Sydney, Australia. 
Durniak began his career in engineering with Johnson & Johnson Orthopedics, leaving to start and manage Texas Direct Medical, an orthopedic product distributorship.  He later re-joined Johnson & Johnson post the acquisition of DePuy, moving through a series of positions before joining Guidant just prior to its acquisition by Boston Scientific.
Durniak holds a BS of Engineering in Biomedical Engineering from the University of Vermont and an MBA from Boston University.

Website: www.MyDario.com

Assessing the use of biometrics for patient identification in healthcare

Michael Trader, President of RightPatient, a biometric patient identification and patient data integrity solution provider helping the healthcare industry to improve patient safety by eliminating duplicate medical records, preventing fraud and medical identity theft, and improving patient data integrity joins eHealth Radio and the Technology and Health Care Channels.
Listen to interview with host Eric Michaels and guest Michael Trader discuss the following: Accurate patient identification and patient data integrity in healthcare is getting a lot of attention because of widespread adoption of EHRs, mHealth tools, and patient portals. What is RightPatient currently doing to help improve patient identification in healthcare?Mobile health apps and patient portals present patient identification challenges to healthcare organizations that user names and passwords can no longer secure. Can you explain how RightPatient is addressing the rising need to secure patient identities from the explosion of new touchpoints for personal health information (PHI) access?I understand that RightPatient has engaged in several strategic partnerships to help augment the effectiveness of your patient identification solution. Can you talk briefly about some of these key partnerships and what you hope to accomplish?RightPatient supports the use of multiple forms of biometrics for patient identification and has 13 years of experience in biometric identification management. Why is this important in the context of providing a biometric patient identification solution to the healthcare industry?If you were a CIO or other decision-maker evaluating this type of technology, what would you look for in a solution?
Duration: 17:41
Michael Trader, Co-Founder and President of RightPatient, helped shepherd the company as a startup to a leader in biometric patient identification technology, patient engagement, and healthcare informatics. As President, he has spearheaded many strategic partnership initiatives and played a crucial role with the company’s product development roadmap. Michael is responsible for overseeing business development and marketing activities, building partnerships, government outreach and providing senior leadership on business and policy issues. His focus is on democratizing and defragmenting healthcare, improving personal and population health outcomes, and lowering costs through technological disruption in the areas of patient identification, engagement, and predictive analytics. Michael is also responsible for management and oversight of M2SYS Technology, a global leader in biometric identification management technology with tens of millions of end users in over 100 countries around the globe.
Prior to joining M2SYS Technology and RightPatient®, he was a key executive and Vice President of Global Sales at BayBuilder where oversaw all global sales activity and developed business relationships with dozens of Fortune 1000 companies to help them implement profitable sourcing methodologies utilizing leading-edge technology. After the acquisition of BayBuilder, Mr. Trader served as the Executive Director of Application Consulting at PurchasePro where he worked closely with other sales and business development executives and managed the product development team. Mr. Trader graduated with honors from the pre-medical program at the Universtiy of Vermont earning a Bachelor's degree in Biological Sciences.

Website: www.rightpatient.com